Pharmacogenomics of coumarin anticoagulants: Are we underestimating the role of CYP2C9?

Tom Schalekamp, Anke-Hilse Maitland-van der Zee, Anthonius de Boer

Research output: Contribution to journal › Editorial › Academic › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	175-176
Journal	Thrombosis and haemostasis
Volume	100
Issue number	2
DOIs	https://doi.org/10.1160/TH08-07-0425
Publication status	Published - 2008
Externally published	Yes

Access to Document

https://doi.org/10.1160/TH08-07-0425

Cite this

@article{0a1c0b88e73a4ed894f47c61abf86926,

title = "Pharmacogenomics of coumarin anticoagulants: Are we underestimating the role of CYP2C9?",

author = "Tom Schalekamp and {Maitland-van der Zee}, Anke-Hilse and {de Boer}, Anthonius",

year = "2008",

doi = "https://doi.org/10.1160/TH08-07-0425",

language = "English",

volume = "100",

pages = "175--176",

journal = "Thrombosis and haemostasis",

issn = "0340-6245",

publisher = "Schattauer GmbH",

number = "2",

}

TY - JOUR

T1 - Pharmacogenomics of coumarin anticoagulants: Are we underestimating the role of CYP2C9?

AU - Schalekamp, Tom

AU - Maitland-van der Zee, Anke-Hilse

AU - de Boer, Anthonius

PY - 2008

Y1 - 2008

U2 - https://doi.org/10.1160/TH08-07-0425

DO - https://doi.org/10.1160/TH08-07-0425

M3 - Editorial

C2 - 18690332

SN - 0340-6245

VL - 100

SP - 175

EP - 176

JO - Thrombosis and haemostasis

JF - Thrombosis and haemostasis

IS - 2

ER -